Short Interest in Silo Pharma, Inc. (NASDAQ:SILO) Drops By 21.8%

Silo Pharma, Inc. (NASDAQ:SILO) was the recipient of a significant decrease in short interest during the month of December. As of December 31st, there was short interest totalling 212,900 shares, a decrease of 21.8% from the December 15th total of 272,100 shares. Based on an average daily volume of 2,920,000 shares, the short-interest ratio is currently 0.1 days. Currently, 5.0% of the shares of the stock are short sold.

Silo Pharma Trading Down 2.2 %

Shares of SILO traded down $0.04 during midday trading on Friday, hitting $1.94. The company’s stock had a trading volume of 128,645 shares, compared to its average volume of 16,240,171. Silo Pharma has a one year low of $0.77 and a one year high of $4.50. The company’s fifty day simple moving average is $1.08 and its two-hundred day simple moving average is $1.24.

Silo Pharma Company Profile

Silo Pharma Inc operates as a developmental stage biopharmaceutical company. The company is developing therapeutics that address underserved conditions, including stress-induced psychiatric disorders, chronic pain conditions, and central nervous system (CNS) diseases. It focuses on developing traditional therapies and psychedelic treatments in formulations and drug delivery systems.